UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia

PloS one, 2022-01, Vol.17 (3), p.e0265278-e0265278

2022

Link zum Volltext

Verfügbarkeit prüfen

Massively parallel digital transcriptional profiling of single cells

Nature communications, 2017-01, Vol.8 (1), p.14049-14049, Article 14049

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase

Journal of clinical oncology, 2009-09, Vol.27 (25), p.4204-4210

2009

Link zum Volltext

Verfügbarkeit prüfen

Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia

Haematologica (Roma), 2024-02, Vol.109 (2), p.401

2024

Link zum Volltext

Verfügbarkeit prüfen

TTMV-RARA fusion as a recurrent cause of AML with APL characteristics

Blood advances, 2022-06, Vol.6 (12), p.3590-3592

2022

Link zum Volltext

Verfügbarkeit prüfen

The significance of bcr-abl molecular detection in chronic myeloid leukemia patients “late,” 18 months or more after transplantation

Blood, 2001-09, Vol.98 (6), p.1701-1707

2001

Link zum Volltext

Verfügbarkeit prüfen

Targeted Sequencing Improves DIPSS-Plus Prognostic Scoring in Myelofibrosis Patients Undergoing Allogeneic Transplantation

Biology of blood and marrow transplantation, 2020-07, Vol.26 (7), p.1371-1374

2020

Link zum Volltext

Verfügbarkeit prüfen

Minimally Invasive Blood Sampling for BCR::ABL1 transcript Monitoring

Blood, 2022-11, Vol.140 (Supplement 1), p.3883-3884

2022

Link zum Volltext

Verfügbarkeit prüfen

Point-of-care BCR::ABL1 transcript monitoring using capillary dried blood in chronic myeloid leukemia patients

Leukemia, 2024-08, Vol.38 (8), p.1822-1824

2024

Link zum Volltext

Verfügbarkeit prüfen

Performance characteristics of the first Food and Drug Administration

PloS one, 2022-03, Vol.17 (3), p.e0265278

2022

Link zum Volltext

Verfügbarkeit prüfen

Performance characteristics of the first Food and Drug Administration assay for BCR::ABL1 monitoring in chronic myelogenous leukemia

PloS one, 2022-03, Vol.17 (3), p.e0265278

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 6483: Performance characteristics of the first FDA-cleared droplet digital PCR (ddPCR) IVD assay for monitoring chronic myelogenous leukemia

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6483-6483

2020

Link zum Volltext

Verfügbarkeit prüfen

Clonal Hematopoiesis in Donor-Recipient Pairs after Allogeneic Hematopoietic Cell Transplantation

Blood, 2019-11, Vol.134 (Supplement_1), p.702-702

2019

Link zum Volltext

Verfügbarkeit prüfen

UPDATE ON SPOT ON CML

Anticancer research, 2019-10, Vol.39 (10), p.5834

2019

Link zum Volltext

Verfügbarkeit prüfen

Patients With Philadelphia-Positive Leukemia With BCR-ABL Kinase Mutations Prior To Allogeneic Transplantation Predominantly Relapse With The Same Mutation

Blood, 2013-11, Vol.122 (21), p.4043-4043

2013

Link zum Volltext

Verfügbarkeit prüfen

SPOT ON CML

Anticancer research, 2018-09, Vol.38 (9), p.5553

2018

Link zum Volltext

Verfügbarkeit prüfen

Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias

Clinical cancer research, 2018-11, Vol.24 (21), p.5321-5334

2018

Link zum Volltext

Verfügbarkeit prüfen

4. Comprehensive next generation cytogenomics improves risk stratification of acute myeloid leukemia

Cancer genetics, 2023-11, Vol.278-279, p.2

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2071: Sub-clonal heterogeneity and risk of treatment failure in Philadelphia-positive leukemias

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2071-2071

2017

Link zum Volltext

Verfügbarkeit prüfen

Single-molecule sequencing reveals patterns of pre-existing drug resistance that suggest treatment strategies in Philadelphia-positive leukemias

Clinical cancer research, 2018-07, Vol.24 (21), p.5321-5334

2018

Link zum Volltext

Verfügbarkeit prüfen

A Novel Somatic Mutation in IKZF1 Is Common in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant for Myelofibrosis

Blood, 2016-12, Vol.128 (22), p.1961-1961

2016

Link zum Volltext

Verfügbarkeit prüfen

Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia

PloS one, 2022-01, Vol.17 (3), p.e0265278

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(16)
Humans
(14)
Hematology
(11)
Chronic Myeloid Leukemia
(8)
Fusion Proteins, Bcr-Abl - Genetics
(8)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics
(8)
Leukemia
(6)
Mutation
(6)
Adult
(5)
Bcr Protein
(5)
Immunology
(5)
Oncology
(5)
Polymerase Chain Reaction
(5)
Transplantation
(5)
Adolescent
(4)
Cancer
(4)
Drug Resistance, Neoplasm - Genetics
(4)
Female
(4)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(16)
Biology Of Blood And Marrow Transplantation
(6)
Plos One
(4)
Cancer Research
(3)
Anticancer Research
(2)
Clinical Cancer Research
(2)
Blood Advances
(1)
Bmc Cancer
(1)
British Journal Of Haematology
(1)
Cancer Cell
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia

Massively parallel digital transcriptional profiling of single cells

Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase

Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia

TTMV-RARA fusion as a recurrent cause of AML with APL characteristics

The significance of bcr-abl molecular detection in chronic myeloid leukemia patients “late,” 18 months or more after transplantation

Targeted Sequencing Improves DIPSS-Plus Prognostic Scoring in Myelofibrosis Patients Undergoing Allogeneic Transplantation

Minimally Invasive Blood Sampling for BCR::ABL1 transcript Monitoring

Point-of-care BCR::ABL1 transcript monitoring using capillary dried blood in chronic myeloid leukemia patients

Performance characteristics of the first Food and Drug Administration

Performance characteristics of the first Food and Drug Administration assay for BCR::ABL1 monitoring in chronic myelogenous leukemia

Abstract 6483: Performance characteristics of the first FDA-cleared droplet digital PCR (ddPCR) IVD assay for monitoring chronic myelogenous leukemia

Clonal Hematopoiesis in Donor-Recipient Pairs after Allogeneic Hematopoietic Cell Transplantation

UPDATE ON SPOT ON CML

Patients With Philadelphia-Positive Leukemia With BCR-ABL Kinase Mutations Prior To Allogeneic Transplantation Predominantly Relapse With The Same Mutation

SPOT ON CML

Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias

Assessment of droplet digital polymerase chain reaction for measuring BCR‐ABL1 in chronic myeloid leukaemia in an international interlaboratory study

4. Comprehensive next generation cytogenomics improves risk stratification of acute myeloid leukemia

Abstract 2071: Sub-clonal heterogeneity and risk of treatment failure in Philadelphia-positive leukemias

Single-molecule sequencing reveals patterns of pre-existing drug resistance that suggest treatment strategies in Philadelphia-positive leukemias

Global Proteomic Profiling Identifies Novel Prognostic Factors in Undifferentiated Leukemia Blasts from Patients with NPM1 Mutations: A Previously Unreported Approach to Biomarker Discovery from the Fred Hutch and SWOG

Proteogenomic Characterization of Highly Enriched Viable Leukemic Blasts in Acute Myeloid Leukemia: A SWOG Report

A Novel Somatic Mutation in IKZF1 Is Common in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant for Myelofibrosis

Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia

Suchergebnisse filtern